September 07, 2017
1 min read
Save

Trial Scorecard: ASSERT-II

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers calculated the rate of detection of subclinical AF using an implantable cardiac monitor (Confirm, St. Jude Medical) in patients with CV risk factors and left atrial enlargement but not confirmed AF.

Trial Scorecard: ASSERT-II